OBJECTIVE: Clinical trials that might identify effective therapies for cancer-related fatigue, one of the most distressing symptoms experienced by patients, require a validated fatigue assessment tool. We developed and validated a Filipino language version of the Brief Fatigue Inventory (BFI-F) for describing the prevalence and severity of fatigue among Filipino patients with cancer. METHODS: We conducted a cross-sectional study in Manila, Philippines, in 206 patients with cancer and 170 age-matched community-dwelling adults who had never had a diagnosis of cancer. Validity and reliability were evaluated by principal factor analysis and Cronbach's α coefficients. RESULTS: Factor analysis extracted 1 factor, i.e. fatigue severity, with a Cronbach's α of 0.95; this is consistent with the original BFI English version validation study. Approximately 49% of the patients with cancer had mild fatigue, 34% had moderate fatigue, and 17% had severe fatigue. Patients with a poorer performance status had significantly worse fatigue than patients with a better performance status (5.0 ± 2.8 vs. 3.8 ± 2.2; p < 0.05). Compared with community adults, the patients with cancer reported significantly higher levels of fatigue. CONCLUSIONS: The BFI-F had satisfactory internal consistency and validity, and it was able to measure the severity of fatigue and its influence on Filipino cancer patients.
OBJECTIVE: Clinical trials that might identify effective therapies for cancer-related fatigue, one of the most distressing symptoms experienced by patients, require a validated fatigue assessment tool. We developed and validated a Filipino language version of the Brief Fatigue Inventory (BFI-F) for describing the prevalence and severity of fatigue among Filipino patients with cancer. METHODS: We conducted a cross-sectional study in Manila, Philippines, in 206 patients with cancer and 170 age-matched community-dwelling adults who had never had a diagnosis of cancer. Validity and reliability were evaluated by principal factor analysis and Cronbach's α coefficients. RESULTS: Factor analysis extracted 1 factor, i.e. fatigue severity, with a Cronbach's α of 0.95; this is consistent with the original BFI English version validation study. Approximately 49% of the patients with cancer had mild fatigue, 34% had moderate fatigue, and 17% had severe fatigue. Patients with a poorer performance status had significantly worse fatigue than patients with a better performance status (5.0 ± 2.8 vs. 3.8 ± 2.2; p < 0.05). Compared with community adults, the patients with cancer reported significantly higher levels of fatigue. CONCLUSIONS: The BFI-F had satisfactory internal consistency and validity, and it was able to measure the severity of fatigue and its influence on Filipino cancerpatients.
Authors: Ehab Y Hanna; Tito R Mendoza; David I Rosenthal; G Brandon Gunn; Pamela Sehra; Emre Yucel; Charles S Cleeland Journal: Cancer Date: 2014-11-04 Impact factor: 6.860
Authors: Tito R Mendoza; Kenneth L Kehl; Oluwatosin Bamidele; Loretta A Williams; Qiuling Shi; Charles S Cleeland; George Simon Journal: Support Care Cancer Date: 2019-01-19 Impact factor: 3.603
Authors: Gianluca Catania; Carol Bell; Simona Ottonelli; Monia Marchetti; Jane Bryce; Alberto Grossi; Massimo Costantini Journal: Support Care Cancer Date: 2012-07-13 Impact factor: 3.603
Authors: Leonora Franke; Eric Therstappen; Beate Schlosser; Michael Biermer; Thomas Berg; Martin Schäfer; Petra Arck; Ralf Uebelhack; Astrid Friebe Journal: Depress Res Treat Date: 2014-03-20